The IFAH critiqued nominees for overall reach, industry impact, market demand and future readiness among other attributes.
Sanuwave also received the Journal for Wound Care 2019 Innovation in Chronic Wound Healing Award for its dermaPACE device in March.
“This recognition is a great opportunity for medical professionals to discover and appreciate the life-changing therapy that Sanuwave’s dermaPACE system can provide to millions of people suffering from diabetic foot ulcers in the U.S. and abroad,” said Mr. Parikh
More articles on devices:
Ortho RTi appoints Pierre Laurin to board of directors — 3 things to know
Zimmer Biomet replaces retiring CFO — 4 insights
VA hospitals, surgeons gain access to bone graft device for spinal fusions
